Education
About Us
Working with TipRanks
Follow Us
Adaptimmune Therapeutics Plc. (DE:473A)
:473A
RESEARCH TOOLSreports
473A Analyst Ratings
Moderate Buy
3 Buy
3 Hold
1 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
473A Stock 12 Month Forecast
Average Price Target
€1.38
▲(527.59%Upside)
| Highest Price Target€2.64 | Average Price Target€1.38 | Lowest Price Target€0.40 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
JonesTrading
―
Hold
―
Reiterated
05/16/25
H.C. Wainwright
€2.64
Buy
1101.70%
Upside
Reiterated
05/14/25
Scotiabank
€1.23
Buy
460.79%
Upside
Reiterated
05/14/25
Wells Fargo
€1.32→€0.88
Hold
300.57%
Upside
Reiterated
05/14/25
Barclays
€0.88→€0.41
Sell
84.26%
Upside
Reiterated
05/14/25
Leerink Partners
€1.76
Hold
701.13%
Upside
Reiterated
05/13/25
Mizuho Securities
―
Buy
―
Reiterated
03/20/25
Guggenheim
€3.52→€2.64
Buy
1101.70%
Upside
Reiterated
11/15/24
TD Cowen
―
Buy
―
Reiterated
11/14/24
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
JonesTrading
―
Hold
―
Reiterated
05/16/25
H.C. Wainwright
€2.64
Buy
1101.70%
Upside
Reiterated
05/14/25
Scotiabank
€1.23
Buy
460.79%
Upside
Reiterated
05/14/25
Wells Fargo
€1.32→€0.88
Hold
300.57%
Upside
Reiterated
05/14/25
Barclays
€0.88→€0.41
Sell
84.26%
Upside
Reiterated
05/14/25
Leerink Partners
€1.76
Hold
701.13%
Upside
Reiterated
05/13/25
Mizuho Securities
―
Buy
―
Reiterated
03/20/25
Guggenheim
€3.52→€2.64
Buy
1101.70%
Upside
Reiterated
11/15/24
TD Cowen
―
Buy
―
Reiterated
11/14/24
Best Analysts Covering Adaptimmune Therapeutics
1 Month
xxx
Success Rate
6/12 ratings generated profit
Average Return
+2.37%
reiterated a xxx
rating 21 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 50.00% of your transactions generating a profit, with an average return of +2.37% per trade.
3 Months
xxx
Success Rate
6/12 ratings generated profit
Average Return
+2.48%
reiterated a xxx
rating 21 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of +2.48% per trade.
1 Year
Success Rate
7/12 ratings generated profit
Average Return
+22.09%
reiterated a sell rating 21 days ago
Copying Peter Lawson's trades and holding each position for 1 Year would result in 58.33% of your transactions generating a profit, with an average return of +22.09% per trade.
2 Years
xxx
Success Rate
8/12 ratings generated profit
Average Return
+35.28%
reiterated a xxx
rating 21 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 66.67% of your transactions generating a profit, with an average return of +35.28% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
473A Analyst Recommendation Trends
Rating
Nov 24
Jan 25
Mar 25
Apr 25
May 25
Strong Buy
10
10
7
4
5
Buy
4
4
3
1
1
Hold
6
6
5
3
6
Sell
3
3
2
1
2
Strong Sell
0
0
0
0
0
total
23
23
17
9
14
Each month's total comprises the sum of three months' worth of ratings.
473A Financial Forecast
473A Stock Forecast FAQ
What is DE:473A’s average 12-month price target, according to analysts?
Based on analyst ratings, Adaptimmune Therapeutics Plc.’s 12-month average price target is 1.38.
What is DE:473A’s upside potential, based on the analysts’ average price target?
Adaptimmune Therapeutics Plc. has 527.59% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Adaptimmune Therapeutics Plc. a Buy, Sell or Hold?
Adaptimmune Therapeutics Plc. has a consensus rating of Moderate Buy, which is based on 3 buy ratings, 3 hold ratings and 1 sell ratings.
What is Adaptimmune Therapeutics Plc.’s share price target?
The average share price target for Adaptimmune Therapeutics Plc. is 1.38. This is based on 7 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €2.64 ,and the lowest forecast is €0.40. The average share price target represents 527.59% Increase from the current price of €0.22.
The highest analyst share price target is €2.64 ,and the lowest forecast is €0.40. The average share price target represents 527.59% Increase from the current price of €0.22.
What do analysts say about Adaptimmune Therapeutics Plc.?
Adaptimmune Therapeutics Plc.’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 7 Wall Streets Analysts.
How can I buy shares of Adaptimmune Therapeutics Plc.?
To buy shares of DE:473A, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.